Condition: Preterm Delivery · Obstetrical Complications · Sponsor: The George Washington University Biostatistics Center
This is a phase-III multi-center double-blind randomized clinical trial of 1,800 individuals with a history of prior preterm birth at less than 35 weeks gestation who are randomized to either 162 mg aspirin or 81 mg aspirin daily. The study drug will be initiated between 10 and 15 weeks gestation and continued through 36 weeks, 6 days gestation. The primary endpoint is recurrent preterm delivery or fetal death prior to 35 weeks, 0 days gestation.
This description comes directly from the study's public registry record.
Rebecca G Clifton, PhD · (301) 881-9260 · rclifton@bsc.gwu.edu
Trisha Boekhoudt, MPH · trishab@bsc.gwu.edu
Always discuss trial participation with your own doctor first.
| University of Alabama - Birmingham | Birmingham, Alabama, United States | Recruiting |
| Regents of the University of California San Francisco | San Francisco, California, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| Columbia University | New York, New York, United States | Recruiting |
| University of North Carolina - Chapel Hill | Chapel Hill, North Carolina, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
| Case Western Reserve University | Cleveland, Ohio, United States | Recruiting |
| Ohio State University | Columbus, Ohio, United States | Recruiting |
| Hospital of the University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
| Magee Women's Hospital of UPMC | Pittsburgh, Pennsylvania, United States | Recruiting |
| Brown University | Providence, Rhode Island, United States | Recruiting |
| Baylor College of Medicine | Houston, Texas, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06980025